ASML vs CAI · P/E 57, $665.37B cap vs rev $216.8M
ASML Holding NV ADR (ASML) versus Caris Life Sciences, Inc. Common Stock (CAI) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
ASML does not have a complete income-statement cache yet.
Latest reported CAI revenue for 2025-09-30 was $216.8M. Net income was $24.3M. Revenue was up 19.5% from 2025-06-30 to 2025-09-30. CAI currently screens at market cap $5.22B.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. CAI currently screens at market cap $5.22B.
Not investment advice. Open the ASML and CAI stock pages for the full models.
Not investment advice.